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ABSTRACT
Objective: To quantify the effect of strategies to
improve retention in randomised trials.
Design: Systematic review and meta-analysis.
Data sources: Sources searched: MEDLINE,
EMBASE, PsycINFO, DARE, CENTRAL, CINAHL,
C2-SPECTR, ERIC, PreMEDLINE, Cochrane
Methodology Register, Current Controlled Trials
metaRegister, WHO trials platform, Society for Clinical
Trials (SCT) conference proceedings and a survey of all
UK clinical trial research units.
Review methods: Included trials were randomised
evaluations of strategies to improve retention
embedded within host randomised trials. The primary
outcome was retention of trial participants. Data from
trials were pooled using the fixed-effect model.
Subgroup analyses were used to explore the
heterogeneity and to determine whether there were any
differences in effect by the type of strategy.
Results: 38 retention trials were identified. Six broad
types of strategies were evaluated. Strategies that
increased postal questionnaire responses were: adding,
that is, giving a monetary incentive (RR 1.18; 95% CI
1.09 to 1.28) and higher valued incentives (RR 1.12;
95% CI 1.04 to 1.22). Offering a monetary incentive,
that is, an incentive given on receipt of a completed
questionnaire, also increased electronic questionnaire
response (RR 1.25; 95% CI 1.14 to 1.38). The
evidence for shorter questionnaires (RR 1.04; 95% CI
1.00 to 1.08) and questionnaires relevant to the
disease/condition (RR 1.07; 95% CI 1.01 to 1.14) is
less clear. On the basis of the results of single trials,
the following strategies appeared effective at increasing
questionnaire response: recorded delivery of
questionnaires (RR 2.08; 95% CI 1.11 to 3.87); a
‘package’ of postal communication strategies (RR 1.43;
95% CI 1.22 to 1.67) and an open trial design (RR
1.37; 95% CI 1.16 to 1.63). There is no good evidence
that the following strategies impact on trial response/
retention: adding a non-monetary incentive (RR=1.00;
95% CI 0.98 to 1.02); offering a non-monetary
incentive (RR=0.99; 95% CI 0.95 to 1.03); ‘enhanced’
letters (RR=1.01; 95% CI 0.97 to 1.05); monetary
incentives compared with offering prize draw entry
(RR=1.04; 95% CI 0.91 to 1.19); priority postal
delivery (RR=1.02; 95% CI 0.95 to 1.09); behavioural
motivational strategies (RR=1.08; 95% CI 0.93 to
1.24); additional reminders to participants (RR=1.03;
95% CI 0.99 to 1.06) and questionnaire question order
(RR=1.00, 0.97 to 1.02). Also based on single trials,
these strategies do not appear effective: a telephone
survey compared with a monetary incentive plus
questionnaire (RR=1.08; 95% CI 0.94 to 1.24); offering
a charity donation (RR=1.02, 95% CI 0.78 to 1.32);
sending sites reminders (RR=0.96; 95% CI 0.83 to
1.11); sending questionnaires early (RR=1.10; 95% CI
0.96 to 1.26); longer and clearer questionnaires
(RR=1.01, 0.95 to 1.07) and participant case
management by trial assistants (RR=1.00; 95% CI 0.97
to 1.04).
Conclusions: Most of the trials evaluated
questionnaire response rather than ways to improve
participants return to site for follow-up. Monetary
incentives and offers of monetary incentives increase
postal and electronic questionnaire response. Some
strategies need further evaluation. Application of these
results would depend on trial context and follow-up
procedures.
INTRODUCTION
Loss of participants during trial follow-up
can introduce bias and reduce power affect-
ing the generalisability, validity and reliability
of results.1 2 If losses are fewer than 5% they
may lead to minimum bias, while 20% loss
can threaten trial validity.2 Missing data from
losses to follow-up can be dealt with statistic-
ally; however, the risk of bias can remain.3
Strengths and limitations of this study
▪ This is the most comprehensive review of strat-
egies specifically designed to improve retention
in randomised trials, including many unpub-
lished trials and data.
▪ Although our searches were extensive, some less
well reported, ongoing, or unpublished trials, or
trials conducted outside the UK might have been
missed.
▪ Most of the evidence relates to increasing ques-
tionnaire response rather than ways to increase
return of participants to sites.
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Trialists adopt various strategies to try to improve
retention and generate maximum data return or compli-
ance to follow-up procedures. These strategies are
designed to motivate and keep participants or site clini-
cians engaged in a trial, but many are untested.4 5 A sys-
tematic review of strategies to retain participants in
cohort studies suggests that providing incentives can
improve retention.6 Edwards’ systematic review on
methods to increase response rates to postal and elec-
tronic questionnaires across a range of study types found
that including monetary incentives, keeping the ques-
tionnaire short and contacting people before question-
naires were sent were ways to increase response rates.7
However, heterogeneity of effects was an issue and it is
unclear which strategies are applicable to randomised
trials. Moreover, reasons for loss to follow-up in cohort
studies and surveys may differ from randomised trials. In
trials, participants may be randomised to a study arm
that is not their preferred choice and so strategies that
improve retention in other study types cannot necessar-
ily be extrapolated to randomised trials.
As loss to follow-up can compromise the validity of
ﬁndings from randomised trials, delay results and poten-
tially increase trial costs, we conducted a systematic
review to assess the effect of strategies to improve reten-
tion in randomised trials.
METHODS
The methods were prespeciﬁed in the Cochrane review
protocol.8
Trials included
We included randomised trials that compared strategies
to increase participant retention embedded in ‘host’
randomised trials across disease areas and settings.
These strategies should have been designed for use after
participants were recruited and randomised. Retention
trials embedded in cohort studies and surveys were
excluded.
Identification of retention trials
We searched MEDLINE (1950 to May 2012), EMBASE
(1980 to May 2012), PsycINFO (1806 to May 2012),
DARE (to May 2012), Cochrane CENTRAL and CINAHL
(1981 to May 2012) using randomised controlled trial
ﬁlters, where possible, and free text terms for retention
(see online supplementary appendix 1 MEDLINE
search). C2-SPECTR (to May 2009) and ERIC (1966 to
May 2009) were only searched to May 2009 because of dif-
ﬁculties encountered with database and search platform
changes. PreMEDLINE was searched to May 2009 but not
subsequently because the free text records ultimately
appear in MEDLINE. For search updates we also
included the Cochrane Methodology Register, Current
Controlled Trials metaRegister of Controlled Trials and
WHO trials registry. Reference lists of relevant publica-
tions, reviews, included studies and abstracts of Society
for Clinical Trials meetings from 1980 to 2012 were also
reviewed. No language restrictions were applied. All UK
clinical trial units were surveyed to identify further eli-
gible trials and the review was advertised at the Society
for Clinical Trials Meeting in 2010.
Trial selection
Two reviewers (VCB and GR) independently screened
potentially eligible trials with disagreements resolved by
a third author (SS). Information was sought from investi-
gators to clarify eligibility where this was unclear.
Data extraction
Data were extracted for each retention and host trial by
one author (VCB) and checked by another (JFT). For
retention trials, data were extracted on start time in rela-
tion to the host trial, aim, primary outcome, follow-up
type, strategy to improve retention and comparator/s,
including the frequency and time the strategy was admi-
nistered, and numbers randomised, included and
retained at the primary analysis. Data on sequence gen-
eration, allocation concealment, blinding and outcome
reporting were extracted for each retention trial to
assess risk of bias.9 Data extracted for each host trial
were: aim, comparators, primary outcome, disease area
and setting. In addition, information on the sequence
generation and allocation concealment was extracted to
conﬁrm that host trials were randomised. Missing or
ambiguous data were queried or obtained through
contact with trial authors.
Statistical analysis
Retention was the primary outcome. Most of the retention
strategies were applied during follow-up for the host trial.
For three host trials, the retention strategy was applied in
further follow-up of trial participants after completion.
For four host trials, the strategy was applied during the
pilot phase, and, for one other host trial, the retention
strategy was applied before the host trial started. Where
retention trials speciﬁed the primary outcome as the
retention rate at a particular time point, this was used in
the analysis. Where trials reported retention at multiple
time points, without specifying which one was the primary
outcome, we used the earliest time point in the analysis to
see the initial impact on retention or response of introdu-
cing the strategy. Where trials reported time to retention,
without specifying the primary time point, we used the
ﬁnal time point in the analysis, taking account of any cen-
soring if data were available.
Retention trials with insufﬁcient data could not be
included in meta-analyses and were described qualita-
tively. Otherwise, risk ratios and their 95% CIs for reten-
tion were used to determine the effect of strategies on
this outcome. The participant was the unit of analysis.
Where clustering was ignored in the analysis of cluster
randomised trials, we inﬂated the SEs using the intra-
class correlation coefﬁcients from appropriate external
sources.10–12
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For factorial trials13 14 that investigated different cat-
egories of strategies to improve retention, we included all
trial comparisons in the relevant analyses and labelled
these accordingly. For one factorial trial,15 where the data
were not available to perform this, only the broad trial
comparisons (main effects) were included in the ana-
lyses. Where there were multiple comparisons in a single
trial16 within the same category of strategy, to avoid
double counting, the intervention arms were combined
and compared with the control arm. Similarly, for
three-armed trials17 18 that compared two similar inter-
vention arms with one control arm, the intervention
arms were combined and compared with the control
arm. For these trials, we also compared each intervention
arm with the control arm, as separate trial comparisons,
in exploratory analyses. Note that these approaches
resulted in more trial comparisons than trials.
Heterogeneity was examined by the χ2 test, at 0.10
level of signiﬁcance, and the I2 statistic,19 and explored
through subgroup analyses. If there was no substantial
heterogeneity, risk ratios were pooled using the
ﬁxed-effect model, but if heterogeneity was detected
and was not explained by subgroup or sensitivity analyses,
we did not pool the results. If heterogeneity could not be
explained, we used the random effects model to assess
the robustness of the results to the choice of model. To
assess the robustness of the results, sensitivity analyses
were conducted that excluded quasi-randomised trials.
The diversity of trials and interventions identiﬁed
meant that not all of our prespeciﬁed subgroup analyses
were appropriate or possible. Therefore, different types
of strategies were analysed separately and new subgroups
were deﬁned within these strategies prior to analysis.
These new analyses are listed in tables 1–4.
The absolute beneﬁts of effective retention strategies
were based on applying meta-analysis risk ratios to repre-
sentative control arm retention rates.20 All statistical ana-
lyses were conducted using RevMan5.
RESULTS
We identiﬁed 38 eligible randomised retention trials from
24 304 records (see online supplementary ﬁgure S4).
Retention trials were embedded in host trials, details of
which are provided in the full Cochrane review.12
Twenty-eight retention trials were published in full,13–
18 21–40 two in the grey literature14 34 and eight are
unpublished (unpublished trials by Edwards, Svobodva, Letley,
Maclennan, Land, Bailey 1, Bailey 2, Marson). Unpublished
trials were identiﬁed by word of mouth, reference lists of
relevant literature and a survey of UK clinical trials units.
Four retention trial publications contained two trials
each.18 32 33 35
Participants and settings
Eligible retention trials were from different geographical
areas and clinical settings. Clinical areas ranged from
exercise and alcohol dependency to treatment and
screening for cancer (tables 1–4).12
Outcomes for strategies to improve retention were
measured by: return of postal or electronic question-
naires13–15 18 21 22 24 25 27 29–34 36–40 (unpublished trials by
Edwards, Svobodva, Letley, Maclennan, Land, Bailey 1, Bailey
2 Marson) or biomedical data17 (Bailey 1, unpublished) , a
combination of postal, telephone and email follow-up35
or face to face follow-up/retention.16 28
Design of included retention trials
One retention trial was cluster randomised (Land
unpublished), four were factorial trials13–16 and there was
one three-armed17 and three four-armed trials.18 32 Five
trials were quasi-randomised,16 28 29 33 allocating partici-
pants by either their identiﬁcation numbers,28 29 day of
clinic visit16 or by random selection of half the sample
for the intervention and half for the control group.33 All
strategies targeted individual trial participants except
one which targeted sites (Land unpublished).
Twenty-nine retention trials started during follow-up of
the host trial13 15 16 18 21 22 24–36 38 41 (Edwards, Land,
Maclennan, Bailey, Svoboda, unpublished). One trial fol-
lowed children of mothers who participated in the MRC
ORACLE trial.39 Two trials followed up participants in
smoking cessation trials after the host trial ﬁnished.17 40
Another retention trial randomised participants before
the host trial started.23 Four trials started during the
pilot phase of the host trial18 32 37 (Letley unpublished).
For one trial, it is unclear when the retention trial
started in relation to the host trial.14
Incentive strategies
There were 14 retention trials of incentives and 19 trial
comparisons. Thirteen trials investigating incentive strat-
egies targeted questionnaire response, with only one tar-
geting participant retention.16 Incentive strategies aimed
at improving questionnaire response were: vou-
chers,18 29 39 cash,25 a charity donation,18 entry into a
prize draw,14 18 30 cheque17 offers of study results24 40
and a certiﬁcate of appreciation.15 16 Incentive strategies
aimed at participant retention were: lapel pins and a cer-
tiﬁcate of appreciation.16 The UK incentives ranged in
value from £5 to £2018 29 39 (Bailey 1, Baily 2, unpub-
lished) and from $2 to $10 for US-based trials, and were
provided as either cash or voucher. Offers of entry into
prize draws ranged from £25 to £250 for UK18 30 and US
$50 for US-based trials14 (table 1); there was no informa-
tion available on the chance of winning a prize. One
trial evaluated giving a monetary incentive with a
promise of a further incentive for return of trial data
(Bailey 2 unpublished).
Communication strategies
There were 14 retention trials of communication strat-
egies and 20 trial comparisons. Most of the communica-
tion strategies targeted questionnaire response, with only
one targeted at the return of biomedical test kits.35
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Table 1 Characteristics of included incentive trials
Trial
Number
randomised
Disease/
condition Participant(s) Setting Intervention(s) Control
Outcome
retention trial
Time point used in
analysis
Addition of monetary incentive vs none
Bauer 2004
(ab)
300 Treatment
smoking
dependence
Smokers US community (a) $10 cheque
(b) $2 cheque
Arms combined
No cheque DNA specimen kit
return plus postal
questionnaire
response
Overall number of kits
returned
Gates 2009 2144 Treatment neck
injury
Patients with
whiplash injury
UK hospital
trusts
£5 voucher No voucher Postal
questionnaire
response at
2 weeks
2 week response
Kenyon 2005 722 Treatment
preterm labour
Women 7 years
post-participation in
ORACLE trial
UK secondary
care/
community
£5 voucher No voucher Postal
questionnaire
response
Overall response
Addition of offer of monetary incentive/prize draw vs none
Khadjesari
2011 (1ac)
1022 Treatment
alcohol
dependence
Adults scoring +5 on
Audit C
UK
Community:
web based
(a) Offer £5
voucher, (c)
Offer entry £250
prize draw
Arms combined
No offer Web-based
questionnaire
response
Response within
40 days of first
reminder
Khadjesari
2011 (2)
2591 Treatment
alcohol
dependence
Adults scoring +5 on
Audit C
Community:
web based
Offer £10
Amazon
voucher
No offer Web-based
questionnaire
response
Response within
40 days of first
reminder
Addition of non-monetary incentive vs none
Bowen 2000
(abc)
4728 Prevention lung
cancer
Adults exposed to
smoking and
asbestos
US sites (a) Certificate,
(b) pin, (c) pin
and certificate
Arms combined
No certificate/
pin
Trial retention Time from
randomisation to first
inactivation (stop
taking vitamins or
placebo) during
PRIDE 2 year
follow-up
Renfroe 2002
(a)
664 Treatment
ventricular
fibrillation
ventricular
tachycardia
Adults cardioverted
from VT or
resuscitated from VF
US hospital Certificate of
appreciation
No certificate Postal
questionnaire
response
Overall response
Sharp 2006
(a)
231 Screening
cervical cancer
Women with
low-grade abnormal
cervical smear
UK primary
care
Pen No pen Postal
questionnaire
response
Overall response
Sharp 2006
(b)
232 Screening
cervical cancer
Women with
low-grade abnormal
cervical smear
UK primary
care
Pen No pen Postal
questionnaire
response
Overall response
Continued
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Table 1 Continued
Trial
Number
randomised
Disease/
condition Participant(s) Setting Intervention(s) Control
Outcome
retention trial
Time point used in
analysis
Sharp 2006
(c)
233 Screening
cervical cancer
Women with
low-grade abnormal
cervical smear
UK primary
care
Pen No pen Postal
questionnaire
response
Overall response
Sharp 2006
(d)
234 Screening
cervical cancer
Women with
low-grade abnormal
cervical smear
UK primary
care
Pen No pen Postal
questionnaire
response
Overall response
Addition of offer of non-monetary incentive vs no offer
Cockayne
2005
1038 Prevention
fracture
Women with hip
fracture risk factors
UK primary
care
Offer of study
results
No offer Postal
questionnaire
response
Overall response
Hughes 1989 100 Treatment
smoking
dependence
Adult smokers US community Offer results
reprint
No offer Postal
questionnaire
response
Overall response
Addition of offer of monetary donation to charity vs no offer
Khadjesari
2011 (1b)
815 Treatment
alcohol
dependence
Adults scoring +5 on
Audit C
Community:
on line
Offer £5 charity
donation
No offer Web-based
questionnaire
response
Response within
40 days of first
reminder
Addition of £10 plus offer of £10 vs addition of £5 plus offer of £5
Bailey (2)
(unpublished)
417 Promotion sexual
health
Young people Community
UK on line
Offer of £20
shopping
voucher
Offer of £10
shopping
voucher
Postal
questionnaire
response
Response at 3-month
follow-up
Addition of £20 voucher offer vs addition of £10 voucher offer
Bailey (1)
(unpublished)
485 Promotion of
sexual health
Young people Community
UK on line
£10 shopping
voucher + offer
of £10 shopping
voucher
£5 shopping
voucher +
offer of £5
shopping
voucher
Postal
questionnaire
response and
chlamydia kit
return
Response at 3-month
follow-up
Addition of monetary incentive vs offer of entry into prize draw
Kenton 2007
(a)
147 Prevention of
postnatal
depression
Women postpartum
at high risk of
postnatal depression
Canada
community
$2 coin Draw for $50
gift voucher
Postal
questionnaire
response
Overall response
Kenton 2007
(b)
150 Prevention of
postnatal
depression
Women postpartum
at high risk of
postnatal depression
Canada
community
$2 coin Draw for $50
gift voucher
Postal
questionnaire
response
Overall response
Offer of prize draw entry vs no offer
Leigh Brown
1997
1307 Clinical
management of
orthopaedic
conditions
Adults non-surgical
musculoskeletal
conditions
UK hospital
out patients
department
Aware offer of
monthly prize
draw of £25 gift
voucher
No offer Postal
questionnaire
response after 1st
and 2nd reminder
No data available
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Table 2 Characteristics of included communication trials
Trial
Number
randomised
Disease/
condition Participants Setting Intervention(s) Control
Outcome
retention trial
Time point used
in analysis
Enhanced letter vs standard letter
Renfroe
2002 (c)
664 Treatment of
ventricular
tachycardia (VT)
ventricular
fibrillation (VF)
Adults
cardioverted
from VT or
resuscitated
from VF
US hospital Cover letter signed
by physician
Cover letter signed
by coordinator
Postal
questionnaire
response
Overall response
Marson
2007
1815 Treatment of
epilepsy
Adults with
epilepsy
UK hospital
outpatient
departments
Letter explaining the
approximate time
needed to complete
the questionnaire
Standard letter Postal
questionnaire
response
Overall response
Total design postal method for postal questionnaires vs customary method
Sutherland
1996
226 Prevention of
breast cancer
Women with
50% breast
volume
dysplasia
Canada
hospital clinic
Total design method
for postal follow-up
Customary method
for postal follow-up
Postal
questionnaire
response
Response at day
70
Priority vs regular post
Renfroe
2002 (b)
664 Treatment of
ventricular
tachycardia (VT)
ventricular
fibrillation (VF)
Adults
cardioverted
from VT or
resuscitated
from VF
US hospital Overnight
questionnaire
delivery
Standard
questionnaire
delivery
Postal
questionnaire
response
Overall response
number of
questionnaires
returned
Sharp 2006
(e)
233 Screening of
cervical cancer
Women with
low-grade
abnormal
cervical smear
UK primary
care
First class outward
post
Second class
outward post
Postal
questionnaire
response
Overall response
Sharp 2006
(f)
231 Screening of
cervical cancer
Women with
low-grade
abnormal
cervical smear
UK primary
care
First class outward
post
Second class
outward post
Postal
questionnaire
response
Overall response
Sharp 2006
(g)
240 Screening of
cervical cancer
Women with
low-grade
abnormal
cervical smear
UK primary
care
Stamped reply
envelope
Business reply
envelope
Postal
questionnaire
response
Overall response
Sharp 2006
(h)
223 Screening of
cervical cancer
Women with
low-grade
abnormal
cervical smear
UK primary
care
Stamped reply
envelope
Business reply
envelope
Postal
questionnaire
response
Overall response
Continued
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Table 2 Continued
Trial
Number
randomised
Disease/
condition Participants Setting Intervention(s) Control
Outcome
retention trial
Time point used
in analysis
Kenton 2007
(c)
149 Screening of
postnatal
depression
Women
postpartum at
high risk of
postnatal
depression
Canada
community
Priority outward mail Regular outward
mail
Postal
questionnaire
response
Overall response
Kenton 2007
(d)
148 Screening of
postnatal
depression
Women
postpartum at
high risk of
postnatal
depression
Canada
community
Priority outward mail Regular outward
mail
Postal
questionnaire
response
Overall response
Additional reminder vs usual follow-up procedures
Ashby 2011 148 Prevention of
migraine
Adults with a
history of two
migraine
attacks
UK
community
Electronic reminder
(email and/or SMS
text)
No electronic
reminder
Postal
questionnaire
response
Response at
40 days
Maclennan
unpublished
753 Prevention of
fracture
Adults with a
history of
osteoporotic
fracture
UK hospital Telephone reminder
(before receiving first
reminder)
No telephone
reminder
Postal
questionnaire
response
Overall response
response rate
Nakash
unpublished
298 Treatment of
ankle injury
Adults with
acute severe
ankle sprain
UK accident
and
emergency
departments
Trial calendar with
questionnaire due
dates
No calendar Postal
questionnaire
response at 4,
12 weeks, and
9 months
Response at
4 weeks
Severi 2011
(1)
1950 Treatment of
smoking
dependence
Adult smokers
willing to quit in
Txt2stop
UK
community
Text message and
fridge magnet
emphasising social
benefits of study
participation
Text message
3 days after
questionnaire sent
reminding
questionnaire is
due
Postal
questionnaire
response
Response at
30 weeks from
randomisation
Severi 2011
(2)
127 Treatment of
smoking
dependence
Adult smokers
willing to quit in
Txt2stop
UK
community
Telephone reminder
from principal
investigator that
participant is
6 weeks overdue
returning their
specimen
Standard text and
no phone call from
principle
investigator
Return of
cotinine samples
Completed cotinine
sample follow-up
for Txt2stop at end
of May 2009
Continued
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Table 2 Continued
Trial
Number
randomised
Disease/
condition Participants Setting Intervention(s) Control
Outcome
retention trial
Time point used
in analysis
Man 2011 125 Treatment of
back pain
Adults with
back pain
UK primary
care
SMS text reminder
message as
follow-up
questionnaire sent
out
No SMS text
message
Postal
questionnaire
response
Overall response
rate
Monthly reminder of upcoming assessment to site vs usual reminders
Land 2007 429 Treatment of
breast cancer
Women with
ductal
carcinoma in
situ
Hospital sites
USA, Canada,
Puerto Rico
Prospective monthly
reminder of
upcoming
assessments to sites
No extra reminders
to sites
Postal
questionnaire
response
Overall response
rate
Early vs late administartion of questionnaire
Renfroe
2002 (d)
664 Treatment of
ventricular
tachycardia (VT)
ventricular
fibrillation (VF)
Adults
cardioverted
from VT or
resuscitated
from VF
US hospital Questionnaire sent
2–3 weeks after last
AVID follow-up visit
Questionnaire sent
1-4 months after
last AVID follow-up
visit
Postal
questionnaire
response
Overall response
number of
questionnaires
returned
Recorded delivery vs telephone reminder
Tai 1997 192 Clinical
management of
asthma and
diabetes
Adults with
asthma or
diabetes
UK primary
care
Recorded delivery
reminder
Telephone
reminder
Postal
questionnaire
response
Overall response
number of
questionnaires
returned
Telephone interview vs questionnaire and monetary incentive
Couper
2007
700 Weight
management
Adults with BMI
>25
US
community
web based
Telephone interview
by trained interviewer
Postal
questionnaires with
$5 bill
Post and
telephone
questionnaire
response
Response at
6 months
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Table 3 Characteristics of included trials evaluating new questionnaire strategies
Trial
Number
randomised
Disease/
condition Participants Setting Intervention(s) Control
Outcome
retention trial
Time point
used in
analysis
Short vs long questionnaire
Dorman 1997 2253 Treatment of
stroke
Patients with
stroke
UK hospital Short EUROQOL
questionnaire
Long SF 36
questionnaire
Postal
questionnaire
response after first
mail out and
reminder
Response
at first time
point
Edwards 2001
unpublished
99 Treatment of
head injury
Head injury
patients
UK hospital
intensive care
units
1-page, 7 question
functional dependence
questionnaire
3-page, 16
question
functional
dependence
questionnaire.
Postal
questionnaire
response
Response
at 3 months
Svoboda 2001
unpublished
91 Treatment of
head injury
Head injury
patients
Czech republic
hospital
intensive care
units
1-page, 7 question
functional dependence
questionnaire
3-page, 16
question
functional
dependence
questionnaire.
Postal
questionnaire
response
Response
at 3 months
McCambridge
2011 1b
2835 Treatment of
alcohol
dependence
Adults scoring
+5 on Audit C
Community
web based
Audit Short (alcohol use
disorders questionnaire)
+
LDQ (Leeds dependancy
questionnaire)
APQ (alcohol
problems
questionnaire)
Web-based
questionnaire
response at
1 month and 3
months
Response
at 1 month
McCambridge
2011 2b
1999 Treatment of
alcohol
dependence
Adults scoring
+5 on Audit C
Community
web based
Audit Short (alcohol use
disorders questionnaire)
+
LDQ (Leeds dependancy
questionnaire)
APQ (alcohol
problems
questionnaire)
Web-based
questionnaire
response at
3 month and 12
months
Response
at 3 months
Long and clear vs short and condensed questionnaires
Subar 2001 900 Screening
prostate, lung,
ovarian,
colorectal cancer
Adults in
PLCO trial
US sites DHQ (36-page food
frequency questionnaire)
PLCO (16-page
food frequency
questionnaire)
Postal
questionnaire/
response on site
completion
Overall
response
Question order: condition first vs generic first questions
McColl 2003 (1) 4751 Clinical
management of
asthma
Adults with
asthma
UK primary
care
Condition-specific
questions first followed
by generic
Generic questions
followed by
condition specific
Postal
questionnaire
response
Overall
response
McColl 2003 (2) 4684 Clinical
management of
angina
Adults with
angina
UK primary
care
Condition-specific
questions followed by
generic
Generic questions
followed by
condition specific
Postal
questionnaire
response
Overall
response
Continued
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Table 3 Continued
Trial
Number
randomised
Disease/
condition Participants Setting Intervention(s) Control
Outcome
retention trial
Time point
used in
analysis
Letley
unpublished. No
data available
Data not
available
Treatment of
back pain
Adults with
low back pain
UK primary
care
23-page self-completion
Roland disability
questionnaire at front and
SF 36 at back
vice versa Questionnaire
response
No data
Questionnaire: relevant vs less relevant to condition
McCambridge
2011 1a
1892 Treatment of
alcohol
dependence
Adults scoring
+5 on Audit C
Community
web based
Alcohol problem
questionnaire (APQ)23
items
Core OM Mental
health
assessment 23/34
items
Web-based
questionnaire
response at 1 and
3 months
Response
at 1 month
McCambridge
2011 2a
2001 Treatment of
alcohol
dependence
Adults scoring
+5 on Audit C
Community
web based
Audit Short (alcohol use
disorders questionnaire)
+ LDQ (Leeds
dependancy
questionnaire)
Core OM Mental
health
assessment 10
items
Web-based
questionnaire
response at 3 and
12 months
Response
at 3 months
Table 4 Characteristics of other trials
Trial
Number
randomised Disease/condition Participants Setting Intervention(s) Control
Outcome retention
trial
Time point used in
analysis
Motivation vs information
Cox
2008
120 Exercise
improvement
Sedentary Women Australia
Community
Motivational
workshops and
newsletters
Information
sheets and
newsletters
Program and trial
retention at 6 and
12 months
6-month and
12-month data. Data
for 6 months used
Chaffin
2009
153 Parenting
improvement
Adults referred for
parenting
improvement
US
community
Self-motivation
information
Standard
information
Program attendance/
trial retention
Retention at
12 weeks
Case management vs usual follow-up
Ford
2006
703 Screening prostate,
lung, ovarian,
colorectal cancer
Adults in the
PLCO screening
trial
US sites In-depth case
management
Regular trial
procedures
Attendance at face to
face cancer
screening
Retention at 3 years
Open vs blind trial design
Avenell
2004
538 Prevention of
fracture
Adults with a
history of
osteoporotic
fracture
UK hospital Open trial design Blind trial design Postal questionnaire
response at 4, 8,
12 months
Response
at12 months
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Strategies evaluated were: enhanced letters, that is, those
with additional information about trial processes or with
an extra feature, for example, signed by a principal
investigator15 (Marson unpublished), use of additional
telephone reminders35 (Maclennan unpublished), a calen-
dar including reminders of when to return a question-
naire34, text and/or email reminders21 31 35 and
reminders to sites of upcoming assessments versus no
additional reminder (Land unpublished). One trial used
a package of postal communication strategies called the
Total Design Method (TDM)37 and another used
recorded delivery of questionnaires38 (table 2).
Five trials evaluated communication and incentive
strategies13–15 25 35 (tables 1 and 2). The incentives were:
certiﬁcates of appreciation for study involvement,15
study-branded pens,13 a US$2 coin14 and a US$5 bill25
or fridge magnets.35 The communication strategies
were: ﬁrst or second class outward post,13–15 stamped
and business reply envelopes,13 letters signed by differ-
ent study personnel,15 letters posted at different times,15
telephone survey25 and text messages.35
New questionnaire formats
The effect of a change in questionnaire format on
response to questionnaires was evaluated in eight trials.
The 10 comparison formats evaluated were (table 3):
questionnaire length27 32 36 (Edwards unpublished Svoboda
unpublished), order of questions (Letley unpublished33)
and relevance of questionnaires in the context of
research in alcohol dependence32.
Behavioural strategies
There were two retention trials of motivational behav-
ioural strategies, one in an exercise trial26 and another
in a parenting trial23 (table 4). A behavioural strategy
was deﬁned as giving participants information about
goal setting and time management to facilitate success-
ful trial completion. One retention trial was run prior to
the host trial,23 where only participants who completed
the orientation/retention trial were included in the sub-
sequent parenting trial.
Case management
Case management deﬁned as outreach, service planning
linkage, monitoring and advocacy was compared with
usual follow-up in a cancer screening trial28 (table 4).
This strategy involved trial assistants managing partici-
pant follow-up by arranging services to enable partici-
pants to keep trial follow-up appointments.
Methodology strategies
One trial included an open trial versus blind trial design
to evaluate the impact on questionnaire response22
(table 4).
Trials not included in the meta-analyses
Two included trials could not be included in the
meta-analysis30 (Letley unpublished). For one trial, the
host trial participants included randomised and non-
randomised participants30 and the author conﬁrmed
that the participants in the retention trial were from
both cohorts and these data could not be separated. For
the other trial, retention trial outcome data were not
available (Letley unpublished).
Risk of bias in included trials
Twenty-four trials describe adequate sequence
generation15 16 18 22–24 26 30–32 34 35 37 39 40 (unpublished
trials Bailey 1, Bailey 2, Letley, Land, Maclennan, Marson).
There was insufﬁcient information about the sequence
generation for 10 trials, but they were all described as
randomised13 14 17 21 25 27 36 38 (Edwards, Svoboda unpub-
lished). Five trials used quasi-randomisation.16 28 29 33
Fifteen trials reported adequate sequence generation
and allocation concealment18 22 24 26 31 32 34 39 40 (Letley,
Maclennan, Bailey 1, Bailey 2, unpublished).
Blinding of participants to the intervention was not
possible for incentive strategies, offers of incentives,
behavioural or case management strategies and different
types of communication and questionnaire format strat-
egies. For one trial that evaluated the effect of a blind
versus open design on retention this was
not applicable.22 For some trials, participants were
aware of the intervention but unaware of the
evaluation14 16 23 30 33 39 (Maclennan, Marson unpub-
lished). For another trial,26 exercise sessions were not
separated according to the behavioural intervention,
that is, walking and swimming, and potential contamin-
ation between groups could have led to bias. For other
trials, blinding of participants or trial personnel to the
outcome or intervention was not reported. The primary
outcome measure for this review was retention, and this
was well reported. Authors were contacted for clariﬁca-
tion of any exclusions after randomisation if this was
unclear from retention trial reports. Although retention
trial protocols were not available for included trials, the
published and unpublished reports included reported
all expected outcomes for retention.
The effects of strategies
Incentive strategies
There were 14 retention trials of incentives, 19 trial com-
parisons with 16 253 comparisons. Across incentive sub-
groups, there was considerable heterogeneity (p<0.00001;
ﬁgure 1A). So we did not pool the results for incentives.
Unless otherwise stated, results from the random effects
model were similar. Three trials (3166 participants) that
evaluated the effect of giving monetary incentives to parti-
cipants showed that the addition of monetary incentives is
more effective than no incentive at increasing response to
postal questionnaires (RR=1.18; 95% CI 1.09 to 1.28;
p<0.0001, heterogeneity p=0.21; ﬁgure 1A). A sensitivity
analysis excluding the quasi-randomised trial by Gates
et al 29 shows a similar effect (RR=1.31; 95% CI 1.11 to 1.55;
p=0.002). Also, based on two web-based trials (3613 partici-
pants, ﬁgure 1A), an offer of a monetary incentive
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promotes greater return of electronic questionnaires than
no offer (RR=1.25; 95% CI 1.14 to 1.38, p<0.00001, hetero-
geneity p=0.14). However, a single trial comparison sug-
gests that an offer of a monetary donation to charity does
not increase response to electronic questionnaires
(RR=1.02, 95% CI 0.78 to 1.32; p=0.90; ﬁgure 1A).
On the basis of three trials (6322 participants), there
is no clear evidence that the addition of non-monetary
incentives improved questionnaire response (RR=1.00;
95% CI 0.98 to 1.02; p=0.91) but there is some hetero-
geneity (p=0.02; ﬁgure 1A). A sensitivity analysis exclud-
ing the quasi-randomised trial by Bowen et al16 showed a
similar effect (RR=1.00; 95% CI 0.93 to 1.08; p=0.99, het-
erogeneity p=0.01). Two trials (1138 participants) evalu-
ating offers of non-monetary incentives suggest that an
offer of a non-monetary incentive is neither more nor
less effective than no offer (RR=0.99; 95% CI 0.95 to
1.03; p=0.60; heterogeneity p=0.52) at improving ques-
tionnaire response (ﬁgure 1A).
In exploratory analyses, the different incentive arms that
were combined for the main analysis do not appear to show
differential effects (see online supplementary ﬁgure S5).
Two trials (902 participants) show that higher value
incentives are better at increasing response to postal
questionnaires than lower value incentives (RR 1.12;
95% CI 1.04 to 1.22; p=0.005; heterogeneity p=0.39) irre-
spective of how they are given (ﬁgure 1B).
Two trial comparisons (297 participants) provide no
clear evidence that giving a monetary incentive is better
than an offer of entry into a prize draw for improving
Figure 1 (A) Incentive strategies: main analysis addition of incentive versus no incentive, (B) incentives: addition of £20 vs £10
incentive, (C) incentives addition of: monetary incentive versus offer of entry into prize draw.
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response to postal questionnaires (RR=1.04; 95% CI 0.91
to 1.19; p=0.56, heterogeneity p=0.18; ﬁgure 1C).
One trial could not be included in the analysis,30 but
showed a higher response in the group offered entry
into a prize draw (70.5%) compared with the group not
offered entry into the draw (65.8%).
Communication strategies
There were 14 trials of communication strategies and 20
comparisons with 9822 participants. The communication
strategies were so diverse that these were analysed
separately.
Results from two trials (2479 participants) show that
an enhanced letter is neither more nor less effective
than a standard letter for increasing response to postal
questionnaires (RR=1.01; 95% CI 0.97 to 1.05; p=0.70;
heterogeneity p=0.80; ﬁgure 2A). Although based on a
single trial (226 participants), the TDM package seems
much more effective than a customary postal communi-
cation method at increasing questionnaire return
(RR=1.43, 95% CI 1.22 to 1.67; p<0.0001; ﬁgure 2B).
Based on the relevant arms of three trials (1888 partici-
pants), there is no clear evidence that priority post is
either more or less effective than regular post at increas-
ing trial questionnaire return (RR=1.02; 95% CI 0.95 to
1.09; p=0.55; heterogeneity p=0.53; ﬁgure 2C).
Six trials (3401 participants) evaluated the effect of
different types of reminders to participants on question-
naire response. There is no clear evidence that a
reminder is either more or less effective than no
reminder (RR=1.03; 95% CI 0.99 to 1.06; p=0.13; hetero-
geneity p=0.73) at improving trial questionnaire response
(ﬁgure 2D). One trial (700 participants) showed no clear
evidence that a telephone survey is either more or less
effective than a monetary incentive and a questionnaire
for improving questionnaire response (RR=1.08; 95% CI
0.94 to 1.24; p=0.27; ﬁgure 2E). Based on one cluster ran-
domised trial (272 participants), a monthly reminder to
sites of upcoming assessment was neither more nor less
effective than the usual follow-up (RR=0.96; 95% CI 0.83
to 1.11; p=0.57). However, one small trial (192 partici-
pants) suggested that recorded delivery is more effective
than a telephone reminder (RR=2.08; 95% CI 1.11 to
3.87; p=0.02). Based on one other trial (664 partici-
pants), there is no clear evidence that sending question-
naires early increased or decreased response (RR=1.10;
95% CI 0.96 to 1.26; p=0.19).
New questionnaire strategies
Eight trials with 10 comparisons (21 505 participants)
evaluated the effect of a new questionnaire format on
questionnaire response. Although there is only some
Figure 1 Continued.
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heterogeneity between the questionnaire subgroups
(p=0.11; ﬁgure 3), it did not seem reasonable to pool
the results based on such different interventions.
Five trials (7277 participants) compared the effect of
short versus long questionnaires on postal questionnaire
response. There is only a suggestion that short question-
naires may be better (RR=1.04; 95% CI 1.00 to 1.08;
p=0.07, heterogeneity p=0.14; ﬁgure 3). Based on one
trial (900 participants), there is no clear evidence that
long and clear questionnaires are more or less effective
than shorter condensed questionnaires for increasing
questionnaire response (RR=1.01, 0.95–1.07; p=0.86;
ﬁgure 3). Two quasi-randomised trials (9435 participants)
also show no good evidence that placing disease/condi-
tion questions before generic questions is either more or
less effective than vice versa at increasing questionnaire
response (RR=1.00, 0.97–1.02; p=0.75, heterogeneity
p=0.44; ﬁgure 3). One trial by Letley (unpublished), not
included in this analysis, provided no estimate of effect.
In the context of research on reducing alcohol con-
sumption, there is also evidence that more relevant
questionnaires, that is, those relating to alcohol use,
increase response rates (RR 1.07; 95% CI 1.01 to 1.14;
p=0.03, ﬁgure 3).
Behavioural/motivational strategies
Two community-based trials (273 participants) show no
clear evidence that the behavioural/motivational strat-
egies used are either more or less effective than stand-
ard information for retaining participants (RR=1.08;
95% CI 0.93 to 1.24; p=0.31, heterogeneity p=0.93).
Case management strategies
One trial (703 participants) evaluated the effect of
intensive case management procedures on retention.
Figure 2 Communication
strategies: (A) enhanced versus
standard letter, (B) total design
versus customary post, (C)
priority versus regular post, (D)
additional reminders to
participants versus usual
follow-up, (E) telephone survey
versus monetary incentive and
questionnaire.
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There is no evidence that intensive case management is
either more or less effective than usual follow-up in the
population examined (RR=1.00; 95% CI 0.97 to 1.04;
p=0.99).
Methodology strategies
One fracture prevention trial (538 participants) evalu-
ated the effect of participants knowing their treatment
allocation (open trial) compared with participants
blind/unaware of their allocation on questionnaire
response. The open design led to higher response rates
(RR=1.37; 95% CI 1.16 to 1.63; p=0.0003).
Absolute benefits of strategies to improve retention
The absolute beneﬁts of effective strategies on typical
questionnaire response are illustrated in table 5. Based
on a 40% baseline response rate for postal question-
naires, the addition of a monetary incentive is estimated
to increase response by 92 questionnaires/1000 sent
(95% CI 50 to 131). With a baseline response rate of
30%, as seen in the included online trial, the addition
of an offer of a monetary incentive is estimated to
increase response by 140 questionnaires/1000 sent
(95% CI 86 to 193).
DISCUSSION
Thirty-eight randomised retention trials were included
in this review, evaluating six broad types of strategies to
increase questionnaire response and retention in rando-
mised trials. Trials were conducted across a spectrum of
disease areas, countries, healthcare and community set-
tings (tables 1–4). Strategies with the clearest impact on
questionnaire response were: addition of monetary
incentives compared with no incentive for return of
postal questionnaires, addition of an offer of a monetary
incentive when compared with none for return of
Figure 3 Questionnaires: new format versus standard format.
Table 5 Absolute benefit of effective strategies to improve retention
Example of proportion of questionnaires returned in
control arm 30% 40% 50% 60% 70% 80% 90%
Strategy to improve retention RR 1/RR
Addition of monetary incentive vs no incentive 1.18 0.847 107 92 76 61 5 3 2
Addition of offer of monetary incentive/prize draw vs no offer 1.25 0.800 140 120 100 80 60 40 20
Addition of higher value monetary incentive vs addition of lower
amount
1.12 0.890 77 66 55 44 33 22 11
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electronic questionnaires and an offer of £20 vouchers
when compared with £10 for return of postal question-
naires and biomedical test kits. The evidence was less
clear about the effect of shorter questionnaires rather
than longer questionnaires and for questionnaires of
greater relevance to the questions being studied.
Recorded delivery of questionnaires, the TDM, a
‘package’ of postal communication strategies with
reminder letters and an open trial design appear more
effective than standard procedures. These strategies
were tested in single trials and may need further evalu-
ation. The addition of a non-monetary incentive or an
offer of a non-monetary incentive compared with no
incentive did not increase or decrease trial question-
naire response. ‘Enhanced’ letters, letters delivered by
priority post or additional reminders were also no more
effective than standard communication. Altering ques-
tionnaire structure does not seem to increase response.
No strategy had a clear impact on increasing the
number of participants returning to sites for follow-up.
Strengths and weaknesses
This is the most comprehensive review of strategies spe-
ciﬁcally designed to improve retention in randomised
trials, including many unpublished trials and data.
Although our searches were extensive, some less well-
reported, ongoing, or unpublished trials, or trials con-
ducted outside the UK might have been missed.
Most of the trials used appropriate methods for ran-
domisation or at least stated that they were randomised.
For trials that did not describe their methods well or
provide further information, there remains a potential
risk of selection bias. Sensitivity analyses excluding
quasi-randomised trials did not affect the results. In this
context, where motivating participants to provide data
or attend clinics is often the target of the interventions
and so appropriately inﬂuences the outcome; lack of
blinding is less of a concern. Retention is the outcome
and was obtained for all but two trials therefore, attrition
and selective outcome reporting bias are probably unim-
portant. Although the retention trials were fairly well
conducted, this could be improved, and they were often
poorly reported. This may be because they were
designed when loss to follow-up became a problem in a
trial, rather than pre-planned prior to the start of the
host trial.
Few trials are available for behavioural, case manage-
ment and methodological strategies (only 1 or 2 each)
and this affects the power of the result for these strat-
egies. The use of open trials to increase questionnaire
response can only be applied to trials where blinding is
not required; based on our result, this strategy would
need to be evaluated in different trial contexts if it were
to be applied in other areas. All included trials were con-
ducted in higher income countries. Therefore, the
effective strategies may not be socially, culturally or eco-
nomically appropriate to trials conducted in low-
resource settings. The diversity of strategies and the low
number of trials meant that we could not examine the
impact of, for example, trial setting and disease area as
planned. Moreover, most of the evidence relates to
increasing questionnaire response rather than partici-
pant retention in follow-up. Many trials require partici-
pants to return to sites for follow-up and monitoring;
however, barriers to follow-up do exist and are trial and
participant speciﬁc depending on the disease area, treat-
ment and population group. Return for follow-up at
sites depends on participant preferences and the
demands of the trial.42 Barriers to follow-up at site could
be alleviated by using tailored strategies to encourage
participants to return to sites for follow-up and monitor-
ing. Studies that evaluate such strategies are particularly
needed.
Edwards’ extensive review of methods to increase
response to postal and electronic questionnaires found
that monetary incentives and recorded delivery of ques-
tionnaires improved response.7 However, unlike our
review, they also found that non-monetary incentives,
shorter questionnaires, use of handwritten addresses,
stamped return envelopes (as opposed to franked return
envelopes) and ﬁrst class outward mailing were effective.
We did, however, ﬁnd that a ‘package’ including an
enhanced letter with several reminders was effective.
The trials included in the Edwards’ review were embed-
ded in surveys, cohort studies and trials, and there was
substantial heterogeneity in the results, which was not a
particular problem in this review.7 Moreover, we
included 8 unpublished trials and 18 other trials not
included by Edwards.12
Nakash et al’s43 small systematic review of ways to
increase response to postal questionnaires in healthcare
was not exclusive to randomised trials. They found
reminder letters, telephone contact and short question-
naires increased response to postal questionnaires.
There was no evidence that incentives were effective. A
systematic review of methods to increase retention in
population-based cohort studies had no meta-analysis,
but suggested that incentives were associated with
increased retention.6
Prior to our review, it was not clear which, if any, of
these strategies could be extrapolated to randomised
trials. We also identiﬁed additional strategies that may
improve trial questionnaire response or retention, for
example, methodological strategies.
Implications
Although giving monetary incentives upfront seems
effective, offering and giving these after receipt of data
could be a cost-effective strategy, because those not
returning questionnaires would not receive an incentive.
The addition of non-monetary incentives, for example,
lapel pins and certiﬁcates of appreciation, or offers of
these, did not increase response or retention, perhaps
because these items are not valued by participants.
Offers of monetary incentives were also an effective strat-
egy in the context of an online electronic questionnaire,
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thus, it would be beneﬁcial for trialists to know which is
more effective: an offer of a monetary incentive or an
upfront monetary incentive in a head-to-head trial
comparison.
The value of incentives used in the UK evaluations
ranged from GBP5 to GBP20 and for US-based studies
was US$2 to US$10. For offers of entries into prize
draws, the values were higher, ranging from GBP25 to
GBP250 for the UK prize draws and US$50 for US-based
prize draws. The value of monetary incentive should not
be so high as to be perceived as payment or coercion for
data but more as an appreciation for efforts made by
participants. A cost-effectiveness analysis for additional
responses gained after incentive strategies were intro-
duced was reported for only some incentive
trials.18 25 29 30 39 As costs increase the cost-beneﬁt asso-
ciated with incentive strategies would need to be
updated if incentives were to be used to improve reten-
tion in future trials.
Priority post, enhanced letters (eg, signed by the prin-
cipal investigator) and different types of additional
reminders are used by trialists in current research prac-
tice, but these were not found to be effective. The
former may not be considered important and too many
reminders, over and above standard procedures, could
be counterproductive.
Although appearing very effective, the TDM for postal
questionnaires could be labour-intensive to implement,
expensive and may no longer be applicable to some par-
ticipant groups, for example, young people used to
other modes of communication, or in trials using email,
text or online data collection. Recorded delivery could
be useful to ensure trial follow-up supplies to reach their
intended destination, but careful planning to avoid
inconvenience for the participant might be necessary.
Open trials to increase questionnaire response can only
be used where blinding is not required. This could be
counterproductive, however, as unblinded trials can
cause biased outcome assessment or loss to follow-up if a
participant or clinician has a treatment preference.
Questionnaire length and relevance may need further
evaluation as there is only a suggestion that these are
effective in the context of randomised trials. Also, tele-
phone follow-up compared with a monetary incentive sent
with a questionnaire needs further evaluation possibly with
a cost-beneﬁt analysis as both could be expensive in time
and human resources. Evaluations of strategies that
encourage participants to return to sites for follow-up visits
and monitoring are particularly needed because many
trials collect outcome data in this way.
Trialists should consider including well thought out and
adequately powered evaluations of strategies to increase
retention in randomised trials with clear deﬁnitions of
retention strategies and retention measures. Trialists could
incorporate evaluations of strategies to improve retention
at the design stage so that power, sample size and funding
are taken into account. Retention trials were often poorly
reported and trialists should adhere to the consort
guidelines for trial reporting to facilitate the synthesis of
results in future methodology reviews.
There is less research on ways to increase return of
participants to trial sites for follow-up and on the effect-
iveness of strategies to retain trial sites in cluster and
individual randomised trials. Research in both areas
would be very beneﬁcial to trialists. Application of the
results of this review would depend on trial setting,
population, disease area, budget allowance and
follow-up procedures.
Conclusions
Trialists should consider using monetary incentives and
offers of monetary incentives to increase postal and elec-
tronic questionnaire response, depending on trial
setting, population, disease area, budget and usual
follow-up procedures.
Future evaluations of retention strategies in rando-
mised trials should be carefully planned and adequately
powered, and the retention strategies and measures of
retention should be clearly deﬁned. More research on
ways to increase return of participants to sites for
follow-up and on ways to retain sites in cluster and indi-
vidual randomised trials are also needed.
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